The bacterial endotoxin lipopolysaccharide (LPS), a key pathogenic stimulator, can induce the activation of macrophages. Activin receptor-interacting protein 2 (ARIP2), an intracellular signaling protein, has a wide histological distribution, however, whether ARIP2 is involved in regulation of activation of macrophages was not well characterized. Here, by immunocytochemical staining, we found that ARIP2 protein existed in monocyte-macrophage cell line RAW264.7 cells and peritoneal macrophages of mouse, and ARIP2 expression in RAW264.7 cells was up-regulated by LPS. Furthermore, the results revealed that ARIP2 overexpression in the LPS-activated RAW264.7 cells inhibited the productions of IL-1β and TNFα, phagocytic activities and CD14 expression, whereas did not alter expressions of MyD88, TLR2 and TLR4. Additionally, in vivo ARIP2 overexpression also reduced the productions of IL-1β and TNFα from the LPS-stimulated peritoneal macrophages of mouse. These data suggest that ARIP2 may play an anti-inflammatory role in macrophages via inhibiting CD14 expression.
ActRIIA and Smad3 mRNA were all detectable in mouse monocyte-macrophage cell line RAW264.7 cells ( Fig. 1A) . Furthermore, the immunocytochemical staining showed that ARIP2 protein was also expressed in RAW264.7 cells and peritoneal macrophages of mouse ( Fig. 1B) , indic-ating that ARIP2 protein exists in mouse macrophages.
Effect of LPS on expression of ARIP2 in macrophages.
To determine whether ARIP2 is engaged in the activation of macrophages, ARIP2 expression was examined in LPS-activated mouse monocyte-macrophage cell line RAW264.7 cells. The results showed that LPS p-romoted the expression of ARIP2 mRNA ( Fig. 2A) , and also enhanced the expression of mature ARIP2 protein in RAW264.7 cells (Fig. 2B ). In addition, by Western blotting, our data further confirmed that LPS increased the levels of ARIP2 protein expression in RAW264.7 cells (Fig. 2C) . These results indicated that the expression of ARIP2 was up-regulated by LPS, suggesting that ARIP2 may be involved in the process of macrophage activation induced by LPS.
Effects of ARIP2 overexpression on cytokines production from RAW264.7 cells. Here, the results revealed the apparently higher levels of ARIP2 mRNA expression in RAW264.7 cells transfected with pcD-NA3-ARIP2 plasmids than those in RAW264.7 cells transfected with control plasmids (Fig. 3A) , indicating that the ARIP2 was successfully overexpressed in RAW264.7 cells. Furthermore, the levels of IL-1β, TNFα and NO in the supernatants of cultured RAW264.7 cells were determined. The results showed that ARIP2 overexpression reduced the production of IL-1β and TNFα from RAW264.7 cells in the presence or absence of LPS, but had no significant effect on NO secretion ( Fig. 3B ), suggesting that ARIP2 overexpression in macrophages might play an anti-inflammatory role through inhibiting pro-inflammatory cytokines IL-1β and TNFα production.
Inhibition of phagocytosis in RAW264.7 cells by ARIP2 overexpression.
Macrophages possess the ability to phagocytose and kill pathogens 22, 23 . In this study, flow cytometry was used to examine the effect of ARIP2 overexpression on phagocytosis of RAW264.7 cells. The result showed that there were lower phagocytic activities to red fluorescent microspheres in ARIP2-overexpressing RAW264.7 cells than those in control plasmid-transfected RAW264.7 cells in the presence or absence of LPS ( Fig. 4 ).
Effect of ARIP2 overexpression on CD14 and TLR2, 4 expressions. LPS stimulates macrophages
to produce inflammatory mediators, which is related to TLR2, 4 and CD14 molecules on cell surface [24] [25] [26] , and LPS-CD14/TLR4 complex conducts signals through intracellular MyD88 and other molecules [27] [28] [29] [30] . Here, we found that ARIP2 overexpression inhibited the expression of TNFα mRNA in RAW264.7 cells, but had no obvious effect on expression of MyD88 mRNA (Fig. 5A ). The flow cytometry analysis indicated that ARIP2 overexpression did not induce the significant changes of TLR2 and TLR4 expression on RAW264.7 cells, compared with control group. Whereas CD14 expression was down-regulated significantly on ARIP2-overexpressing RAW264.7 cells, compared with that on control RAW264.7 cells ( Fig. 5B ), suggesting that ARIP2 may inhibit pro-inflammatory cytokines via attenuating the expression of CD14 on the surface of macrophages. 
Inhibitory effects of in vivo ARIP2 overexpression on production of inflammatory cytokines of peritoneal macrophages of mouse.
To further verify the anti-inflammatory role of ARIP2 in macrophages, peritoneal macrophages of mouse were transfected in vivo with pcDNA3-ARIP2 expressing plasmid. The results showed that the level of ARIP2 mRNA expression was exactly higher in ARIP2-overexpressing mouse peritoneal macrophages than those in the control plasmid group (Fig. 6A ), indicating that the ARIP2 was successfully overexpressed in vivo in mouse peritoneal macrophages transfected with pcDNA3-ARIP2 plasmids. Furthermore, we found that ARIP2 overexpression significantly inhibited productions of IL-1β and TNFα in LPS-activated mouse peritoneal macrophages ( Fig. 6B ), indicating that in vivo ARIP2 overexpression also had anti-inflammatory role in LPS-activated macrophages via reducing the release of inflammatory cytokines.
Discussion
Macrophages are not only important innate immune cells in body defense system, but also the main cells that are involved in inflammatory response, for example, macrophages participate in acute phase response in inflammatory diseases via secreting pro-inflammatory cytokines TNFα, IL-1β and IL-6, et al. [31] [32] [33] [34] . As a major component of Gram-negative bacterial cells wall and the main molecular basis of pathogenesis, LPS can induce the activation and maturation of monocytes-macrophages primarily through binding the CD14/TLR4/MD2 receptor complex, resulting in the release of large number of inflammatory mediators, such as NO, TNFα and IL-1β, etc. 28, 30, 35 . If the activated macrophages sustain the release of excessive inflammatory mediators, it can lead to excessive or uncontrolled inflammatory responses, causing damage to the body 36, 37 . In this study, the focus is to investigate the negative regulation of the activated macrophages.
ARIPs belong to activin signal transduction proteins, localized at upstream of Smad signal cascade. ARIP1 has two WW and five PDZ-like domains, interacting with ActRII through the fifth PDZ domain, and inhibits activin signaling transduction 38 . ARIP2 only has one PDZ domain, and binds ActRII through this PDZ domain. Furthermore, ARIP2 can also interact with RalBP1 (Ral-binding protein 1) through its C-terminal peptide to mediate activin receptor endocytosis, and ARIP2 overexpression in mouse hepatoma Hepa1-6 cells can inhibit production of collagen type IV 17, 19 . However, it is still unclear whether LPS can affect the expression of ARIP2 protein in macrophages and ARIP2 is involved in the negative regulation of LPS-activated macrophages.
Previous our studies have reported that ARIP2 widely distributed in the heart, lung, kidney, pancreas, brain and other tissues [18] [19] [20] [21] . Therefore, in order to identify the relationship of ARIP2 expression and LPS response in macrophages, we first detected the expression of ARIP2 in mouse peritoneal macrophages and monocyte-macrophage cell line RAW264.7 cells. RT-PCR and immunocytochemical staining showed that ARIP2 was expressed in mouse peritoneal macrophages and RAW264.7 cells. Furthermore, our data showed that LPS up-regulated ARIP2 expression in RAW264.7 cells, suggesting that ARIP2 as activin signaling protein may be also involved in the process of macrophages activation induced by LPS.
As essential innate immune cells, macrophages clear antigens by phagocytosis, pinocytosis, etc. In addition macrophages are involved in inflammatory responses through the release of inflammatory mediators NO, TNFα and IL-1β 36, 37 . Here, we further examined the biological activities of ARIP2 in macrophages. The data indicated that in vitro ARIP2 overexpression reduced the production of IL-1β and TNFα in RAW264.7 cells treated with LPS, but had no significant effect on NO secretion. We also found that ARIP2 overexpression inhibited the phagocytosis of LPS-activated RAW264.7 cells significantly. Similar results were found in which in vivo ARIP2 overexpression also inhibited IL-1β and TNFα production in LPS-activated mouse peritoneal macrophages. These data indicated that ARIP2 expressed in macrophages might play an anti-inflammatory role via down-regulating IL-1β and TNFα secretion and phagocytosis.
Macrophage activation and synthesis or secretion of cytokines are related to TLRs. TLR2 recognizes lipoteichoic acids and other compounds, and TLR4 interacts with LPS. As a TLR4 agonist, LPS binds to CD14 and TLR4 complexes, and then activates macrophages through the MyD88-dependent and MyD88-independent pathway [28] [29] [30] . Therefore, in order to elucidate the anti-inflammatory mechanism of ARIP2 overexpression in LPS-activated macrophages, we further examined the expression of MyD88, TLR2, 4 and CD14. The results showed that ARIP2 overexpression significantly down-regulated the expression of TNFα mRNA in RAW264.7 cells, but did not alter the expression of MyD88 mRNA. We also found that ARIP2 overexpression had no appreciable effect on the expression of TLR2 and TLR4 on RAW264.7 cells, but significantly inhibited the expression of CD14. These results suggested that ARIP2 may reduce the binding of LPS to CD14/TLR4 complex via down-regulating the expression of CD14, leading to inhibition of macrophage activation.
In summary, these data indicate that ARIP2 protein is expressed in macrophages, and its expression can be regulated by LPS. The increased ARIP2 in the LPS-activated macrophages may play an anti-inflammatory role via inhibiting the production of pro-inflammatory cytokines by feedback regulation, which is related to the inhibition of CD14 expression on macrophages. Immunocytochemistry staining. RAW264.7 cells and peritoneal macrophages of mouse were seeded into 96-well plates at a density of 4 × 10 4 cells per well, respectively, and incubated in 10% FBS-high glucose DMEM medium for 24 h at 37 °C under 5% CO 2 . The cells were fixed with 4% paraformaldehyde and incubated in 3% H 2 O 2 at room temperature (RT) for 10 min. Non-specific reactivity was blocked by a pre-incubation with 2% bovine serum albumin (BSA) for 30 min at RT. The cells were incubated in rabbit anti-mouse ARIP2 antibody (1:400) overnight at 4 °C 21 , and then processed with biotinylated secondary antibodies for 10 min at RT. The cells were further treated with streptomycete-horse-radish peroxidase for 10 min at RT. Immunoreactive products were visualized by 0.03% H 2 O 2 and 0.05% diaminobenzidine (DAB). The cells were counterstained by hematoxylin counter stain and images captured on a Nikon Eclipse E400 light microscope (Nikon Corporation, Tokyo, Japan). In order to control staining, the cells were incubated with normal rabbit IgG instead of anti-ARIP2 antibody.
RT-PCR.
Total RNA was extracted from RAW264.7 cells using TRIzol reagent (Takara, Dalian, China) according to manufacturer's instructions and cDNA synthesis was carried out using PrimeScript ® 1st Strand cDNA Synthesis Kit (Takara). PCR was performed with target gene-specific primer listed in Table 1 . PCR products were separated by electrophoresis on 1.5% agarose, and stained with ethidium bromide. The specific bands were analyzed using IMAGEMASTER VDS (Pharmacia Biotech Company, Uppsala, Sweden).
Western blotting. Raw264.7 cells were lysed using M-PER ® Mammalian Protein Extraction Reagent (Thermo Scientific) containing Halt TM Protease Inhibitors (Thermo Scientific) and centrifuged at 12,000 × g at 4 °C for 30 min, and then the proteins were quantified using the Peirce TM BCA protein assay kit (Thermo Scientific) following the manufacturer's instruction. 30 μg of proteins were separated by electrophoresis with 12% SDS-PAGE gel, and transferred onto a polyvinylidene difluoride membrane. The membranes were blocked for 1 h and then exposed to an antibody against ARIP2 (1:500) or GAPDH (1:3000, Sungene Biotech) at 4 °C overnight in blocking buffer. The membranes were then probed with a horseradish peroxidase-conjugated second antibody. Finally, the labeled proteins were detected by chemiluminescence (ECLPlus; Amersham Pharmacia Biotech).
ARIP2 overexpression in vitro in RAW264.7 cells. RAW264.7 cells in logarithmic growth phase were seeded into 12-well cell culture plates at a density of 4 × 10 5 cells/ml, and the cells were transfected with pcDNA3 empty plasmids and pcDNA3-ARIP2 expressing plasmids, respectively, by using the X-tremeGENE HP transfection reagent (Roche) according to the manufacturer's protocol for 12 h. The transfected RAW264.7 cells were incubated in 2% FBS-DMEM medium in the presence or absence of LPS (500 ng/ml) for 12 h. The supernatants of the cultured cells were collected for ELISA and the cell pellets were used for RT-PCR analysis.
Detection of IL-1β and TNFα. The supernatants of the cultured RAW264.7 cells were collected, and levels of interleukin-1β (IL-1β) and tumour necrosis factor-α (TNF-α) were examined by ELISA kit according to the manufacturer's protocol (eBioscience).
Assay of phagocytosis. RAW264.7 cells were transfected with pcDNA3 empty plasmids and pcD-NA3-ARIP2 expressing plasmids, respectively, and then incubated in 2% FBS-DMEM medium in the presence or absence of LPS (500 ng/ml) for 12 h, followed by incubating with 1 × 10 7 red fluorescent microspheres/well for 1 h, rinsed with pH 7.4, 0.01 mol/L phosphate-buffered saline (PBS). Phagocytosis ratio was performed by flow cytometry (New Jersey, USA, BD Calibur).
Flow cytometry. Raw264.7 cells were incubated in FITC-conjugated anti-mouse TLR2, and PE-conjugated anti-mouse TLR4 or CD14 antibodies for 30 min at RT, respectively, meanwhile isotype IgG of each antibody was incubated as control. The labeled cells were analyzed by flow cytometry (BD Calibur). The data were collected and analyzed with FlowJo 7.6 to assess the percentage of fluorescence positive cells.
ARIP2 overexpression in vivo in mouse peritoneal macrophages. Mice were randomly divided into pcDNA3 empty plasmid group and pcDNA3-ARIP2 expressing plasmid group after 7 days of adaptive feeding, and treated in vivo with ARIP2-expressing plasmid pcDNA-ARIP2 and control empty plasmid pcDNA3, respectively. Briefly, the pcDNA-ARIP2 plasmids (3 μg/mouse) or control pcDNA3 plasmids (3 μg/mouse) were enfolded by X-tremeGENE HP and then injected into mice via intraperitoneal injection. 12 h post-injection of plasmids, the mice peritoneal macrophages were isolated and cultured as previously described 24 .
Statistical analysis. The data were expressed as mean ± standard deviation (SD), and statistical evaluation was performed by statistical software SPSS 17.0. Differences of P < 0.05 were considered statistically significant.
